Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21593) 21593
Newsletter (4739) 4739
Newspaper Article (2089) 2089
Publication (1719) 1719
Book Review (376) 376
Book Chapter (144) 144
Trade Publication Article (128) 128
Magazine Article (72) 72
Dissertation (69) 69
Transcript (56) 56
Book / eBook (43) 43
Conference Proceeding (41) 41
Web Resource (27) 27
Journal / eJournal (3) 3
Data Set (2) 2
Government Document (2) 2
Paper (2) 2
Reference (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lupus (13526) 13526
humans (13160) 13160
systemic lupus erythematosus (10992) 10992
female (9045) 9045
index medicus (7226) 7226
nephritis (6919) 6919
male (6449) 6449
adult (6275) 6275
rheumatology (6050) 6050
lupus nephritis (5196) 5196
research (4541) 4541
middle aged (4079) 4079
animals (3625) 3625
immunology (3336) 3336
lupus erythematosus, systemic - immunology (3184) 3184
mice (2893) 2893
adolescent (2856) 2856
disease (2591) 2591
erythematosus (2591) 2591
lupus erythematosus, systemic - complications (2548) 2548
autoimmune diseases (2400) 2400
medical research (2293) 2293
autoantibodies (2256) 2256
kidney diseases (2166) 2166
autoimmunity (2075) 2075
urology & nephrology (2048) 2048
medicine, experimental (2026) 2026
systemic-lupus-erythematosus (1923) 1923
lupus erythematosus, systemic - drug therapy (1880) 1880
lupus nephritis - immunology (1803) 1803
reports (1800) 1800
care and treatment (1737) 1737
lupus nephritis - pathology (1729) 1729
glomerulonephritis (1727) 1727
risk factors (1727) 1727
biopsy (1716) 1716
analysis (1582) 1582
lupus nephritis - drug therapy (1580) 1580
immunosuppressive agents - therapeutic use (1562) 1562
young adult (1554) 1554
aged (1537) 1537
child (1535) 1535
classification (1524) 1524
kidney - pathology (1469) 1469
prognosis (1445) 1445
skin and connective tissue diseases (1430) 1430
sle (1412) 1412
antibodies (1353) 1353
patients (1353) 1353
treatment outcome (1296) 1296
lupus erythematosus, systemic - diagnosis (1266) 1266
inflammation (1218) 1218
retrospective studies (1215) 1215
cyclophosphamide (1213) 1213
disease-activity (1211) 1211
lupus erythematosus, systemic - pathology (1201) 1201
lupus erythematosus, systemic - genetics (1200) 1200
arthritis (1173) 1173
kidneys (1168) 1168
expression (1166) 1166
medicine (1166) 1166
health aspects (1158) 1158
universities and colleges (1125) 1125
rheumatoid-arthritis (1100) 1100
immune system diseases (1083) 1083
pathogenesis (1072) 1072
severity of illness index (1072) 1072
diagnosis (1069) 1069
research article (1055) 1055
medicine, general & internal (1033) 1033
therapy (1001) 1001
lupus erythematosus, systemic - blood (992) 992
drug therapy (980) 980
immunoglobulins (955) 955
cytokines (944) 944
disease models, animal (932) 932
proteins (932) 932
mortality (928) 928
lupus nephritis - diagnosis (882) 882
enzyme-linked immunosorbent assay (871) 871
nephrology (866) 866
lupus nephritis - complications (865) 865
proteinuria (862) 862
case-control studies (861) 861
studies (854) 854
pregnancy (852) 852
genetic aspects (845) 845
article (823) 823
development and progression (812) 812
apoptosis (806) 806
clinical trials (773) 773
lupus erythematosus, systemic - physiopathology (764) 764
follow-up studies (756) 756
pediatrics (754) 754
gene expression (751) 751
health risk assessment (738) 738
dna - immunology (732) 732
transplantation (731) 731
medicine, research & experimental (729) 729
time factors (725) 725
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
Online Resources - Online (5) 5
Sunnybrook Health Sciences Centre - Holland Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Reference (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27071) 27071
Japanese (354) 354
German (267) 267
Spanish (251) 251
French (207) 207
Russian (202) 202
Chinese (156) 156
Korean (134) 134
Polish (58) 58
Portuguese (50) 50
Italian (44) 44
Hungarian (23) 23
Serbian (23) 23
Turkish (15) 15
Croatian (11) 11
Czech (10) 10
Bulgarian (9) 9
Finnish (6) 6
Hebrew (6) 6
Persian (6) 6
Arabic (5) 5
Dutch (5) 5
Danish (4) 4
Norwegian (3) 3
Slovak (3) 3
Swedish (3) 3
Bosnian (2) 2
Romanian (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort
by Dall'Era, Maria and Cisternas, Miriam G and Smilek, Dawn E and Straub, Laura and Houssiau, Frédéric A and Cervera, Ricard and Rovin, Brad H and Mackay, Meggan
Arthritis & Rheumatology, ISSN 2326-5191, 05/2015, Volume 67, Issue 5, pp. 1305 - 1313
Objective. There is a need to determine which response measures in lupus nephritis trials are most predictive of good long-term renal function. We used data... 
IMMUNOSUPPRESSIVE THERAPY | MANAGEMENT | EFFICACY | CYCLOPHOSPHAMIDE | SAFETY | AZATHIOPRINE | RHEUMATOLOGY | MYCOPHENOLATE-MOFETIL | ABATACEPT | Glucocorticoids - therapeutic use | Hematuria | Humans | Disease Progression | Lupus Nephritis - blood | Renal Insufficiency, Chronic - blood | Lupus Nephritis - urine | Biomarkers | Creatinine - blood | ROC Curve | Longitudinal Studies | Cohort Studies | Proteinuria | Renal Insufficiency, Chronic - urine | Lupus | Health risk assessment | Medical research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Lupus nephritis
by Korbet, Stephen M and Lewis, Edmund J., 1936 and Schwartz, Melvin M., Prof
1999, Oxford clinical nephrology series, ISBN 9780192627551, xiii, 315
Lupus Nephritis
Book
Details down arrow
3. Full Text Update on lupus nephritis
by Almaani, Salem and Meara, Alexa and Rovin, Brad H
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2017, Volume 12, Issue 5, pp. 825 - 835
SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and... 
Glomerulonephritis | Discoid | Nephritis | Humans | Systemic | Lupus nephritis | Kidney | Risk factors | Chronic | Immunosuppression | Kidney failure | Renal Insufficiency | Systemic lupus erythematosus | Glomerular disease | Epidemiology and outcomes | Lupus Erythematosus | REPEAT BIOPSY | RISK-FACTORS | THERAPY | KIDNEY BIOPSY | UROLOGY & NEPHROLOGY | AFRICAN-AMERICANS | 3 ETHNIC-GROUPS | STAGE RENAL-DISEASE | ERYTHEMATOSUS | I INTERFERON | INDUCTION TREATMENT | Predictive Value of Tests | Genetic Predisposition to Disease | Lupus Nephritis - genetics | Prognosis | Kidney - pathology | Risk Factors | Disease Progression | Phenotype | Kidney Failure, Chronic - epidemiology | Biopsy | Lupus Nephritis - physiopathology | Lupus Nephritis - therapy | Lupus Nephritis - epidemiology | Kidney - physiopathology | risk factors | Glomerular Diseases | Update for the Clinican | kidney failure | immunosuppression | glomerular disease | nephritis | kidney | systemic lupus erythematosus | lupus nephritis | glomerulonephritis | humans | chronic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
by Houssiau, Frédéric A and D'Cruz, David and Sangle, Shirish and Remy, Philippe and Vasconcelos, Carlos and Petrovic, Radmila and Fiehn, Christoph and de Ramon Garrido, Enrique and Gilboe, Inge-Magrethe and Tektonidou, Maria and Blockmans, Daniel and Ravelingien, Isabelle and le Guern, Véronique and Depresseux, Geneviève and Guillevin, Loïc and Cervera, Ricard and MAINTAIN Nephritis Trial Grp and MAINTAIN Nephritis Trial Group and the MAINTAIN Nephritis Trial Group
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2010, Volume 69, Issue 12, pp. 2083 - 2089
Background Long-term immunosuppressive treatment does not efficiently prevent relapses of lupus nephritis (LN). This investigator-initiated randomised trial... 
THERAPY | RHEUMATOLOGY | METHYLPREDNISOLONE | CYCLOPHOSPHAMIDE | ERYTHEMATOSUS | DISEASE-ACTIVITY | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Treatment Outcome | Secondary Prevention | Cyclophosphamide - therapeutic use | Young Adult | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Adult | Female | Immunosuppressive Agents - adverse effects | Prednisolone - therapeutic use | Drug Therapy, Combination | Azathioprine - adverse effects | Nephritis | Safety and security measures | Patient outcomes | Dosage and administration | Research | Mycophenolate mofetil | Azathioprine | Drug therapy | Lupus | Pregnancy | Biopsy | Laboratories | Rodents | Blood pressure | Kidney diseases | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis
by Tektonidou, Maria G and Dasgupta, Abhijit and Ward, Michael M
Arthritis & Rheumatology, ISSN 2326-5191, 06/2016, Volume 68, Issue 6, pp. 1432 - 1441
Objective. End-stage renal disease (ESRD) is a major consequence of lupus nephritis, but how this risk has changed over time is unknown. We conducted this... 
MORTALITY | SURVIVAL | PREDNISONE | MANAGEMENT | MORBIDITY | COHORT | RHEUMATOLOGY | ASSOCIATION | SOCIOECONOMIC-STATUS | ERYTHEMATOSUS | EPIDEMIOLOGY | Kidney Failure, Chronic - epidemiology | Risk Assessment | Time Factors | Humans | Bayes Theorem | Lupus Nephritis - complications | Kidney Failure, Chronic - etiology | Confidence intervals | Lupus | Medicare | Industrialized nations | Kidney diseases | Health risk assessment | Developing countries--LDCs
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The pathogenesis of lupus nephritis
by Lech, Maciej and Anders, Hans-Joachim
Journal of the American Society of Nephrology, ISSN 1046-6673, 09/2013, Volume 24, Issue 9, pp. 1357 - 1366
Lupus nephritis is an immune complex GN that develops as a frequent complication of SLE. The pathogenesis of lupus nephritis involves a variety of pathogenic... 
ANTIBODIES | DENDRITIC CELLS | CELL DNA METHYLATION | ACTIVATE B-CELLS | MURINE LUPUS | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | RENAL-DISEASE | PLASMA-CELLS | ERYTHEMATOSUS | I INTERFERON | Lupus Nephritis - etiology | Lupus Erythematosus, Systemic - complications | Lymphocytes - pathology | Antibodies, Antinuclear - physiology | Humans | Lupus Nephritis - physiopathology | Signal Transduction - physiology | Lupus Nephritis - immunology | Interferon-alpha - physiology | Up Front Matters
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Lupus Nephritis
by Wenderfer, Scott E and Eldin, Karen W
Pediatric Clinics of North America, ISSN 0031-3955, 02/2019, Volume 66, Issue 1, pp. 87 - 99
Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a... 
Lupus | Nephritis | Hematuria | Biopsy | Autoantibody | Complement | Glomerulopathy | Proteinuria | RHEUMATOID-ARTHRITIS | EFFICACY | ERYTHEMATOSUS | CHILDREN | THERAPY | PEDIATRICS | OUTCOMES | STAGE RENAL-DISEASE | MYCOPHENOLATE-MOFETIL | ONSET | INDUCTION TREATMENT
Journal Article
Details down arrow
8. Full Text Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis—Should MMF Be Considered the Drug of Choice?
by Brad H. Rovin and Samir V. Parikh and Lee A. Hebert and Tak Mao Chan and Chi Chiu Mok and Ellen M. Ginzler and Lai Seong Hooi and Paul Brunetta and Romeo Maciuca and Neil Solomons
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2013, Volume 8, Issue 1, pp. 147 - 153
Severe lupus nephritis is an aggressive disease that requires an aggressive approach to treatment. Recent randomized clinical trials showed that mycophenolate... 
LONG-TERM | CONTROLLED-TRIAL | PREDNISONE | INTRAVENOUS CYCLOPHOSPHAMIDE | UROLOGY & NEPHROLOGY | RENAL-DISEASE | REGIMENS | MYCOPHENOLATE-MOFETIL | MAINTENANCE THERAPY | PULSE METHYLPREDNISOLONE | REMISSION | Severity of Illness Index | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Lupus Nephritis - drug therapy | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Treatment for lupus nephritis
by Henderson, Lorna and Masson, Philip and Craig, Jonathan C and Flanc, Robert S and Roberts, Matthew A and Strippoli, Giovanni F M and Webster, Angela C
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 12, Issue 12, p. CD002922
Background Cyclophosphamide, in combination with corticosteroids has been used to induce remission in proliferative lupus nephritis, the most common kidney... 
LONG-TERM | PULSE INTRAVENOUS CYCLOPHOSPHAMIDE | Humans | ORAL MYCOPHENOLATE-MOFETIL | RENAL-FUNCTION | Immunosuppressive Agents [therapeutic use] | RANDOMIZED CONTROLLED-TRIAL | CHRONIC PLASMA-EXCHANGE | Azathioprine [therapeutic use] | MAINTENANCE THERAPY | Randomized Controlled Trials as Topic | DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS | Lupus Nephritis [drug therapy] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [therapeutic use] | INDUCTION THERAPY | TERM-FOLLOW-UP | Cyclophosphamide [therapeutic use] | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Lupus Nephritis - drug therapy | Cyclophosphamide - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Maintenance Chemotherapy - methods | Adult | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Multitarget therapy for induction treatment of lupus nephritis: a randomized trial
by Liu, Zhihong and Liu, Zhihong and Zhang, Haitao and Zhang, Haitao and Liu, Zhangsuo and Liu, Zhangsuo and Xing, Changying and Xing, Changying and Fu, Ping and Fu, Ping and Ni, Zhaohui and Ni, Zhaohui and Chen, Jianghua and Chen, Jianghua and Lin, Hongli and Lin, Hongli and Liu, Fuyou and Liu, Fuyou and He, Yongcheng and He, Yongcheng and He, Yani and He, Yani and Miao, Lining and Miao, Lining and Chen, Nan and Chen, Nan and Li, Ying and Li, Ying and Gu, Yong and Gu, Yong and Shi, Wei and Shi, Wei and Hu, Weixin and Hu, Weixin and Liu, Zhengzhao and Liu, Zhengzhao and Bao, Hao and Bao, Hao and Zeng, Caihong and Zeng, Caihong and Zhou, Minlin and Zhou, Minlin
Annals of internal medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 1, pp. 18 - 26
Background: Treatment of lupus nephritis (LN) remains challenging. Objective: To assess the efficacy and safety of a multitarget therapy consisting of... 
MEDICINE, GENERAL & INTERNAL | PROSPECTIVE MULTICENTER | HISTOLOGIC DATA | CLINICAL-TRIALS | INTRAVENOUS CYCLOPHOSPHAMIDE | MISSING DATA | RENAL-TRANSPLANTATION | TACROLIMUS | MYCOPHENOLATE-MOFETIL | ERYTHEMATOSUS | CYCLOSPORINE | Glucocorticoids - therapeutic use | Prospective Studies | Kidney - pathology | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Adult | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Lupus Nephritis - pathology | Prednisone - adverse effects | Tacrolimus - adverse effects | Remission Induction | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Pilot Projects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Biopsy | Adolescent | Immunosuppressive Agents - adverse effects | Aged | Prednisone - therapeutic use | Lupus | Complications and side effects | Drug targeting | Nephritis | Drug therapy | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Lupus nephritis
by Cameron, J. Stewart
Journal of the American Society of Nephrology, ISSN 1046-6673, 02/1999, Volume 10, Issue 2, pp. 413 - 424
PLASMAPHERESIS | PREDNISONE | CONTROLLED TRIAL | THERAPY | DRUGS | UROLOGY & NEPHROLOGY | RISK | RENAL-TRANSPLANTATION | PULSE CYCLOPHOSPHAMIDE | ERYTHEMATOSUS | DISEASE-ACTIVITY | Lupus Nephritis - pathology | Autoimmunity - physiology | Prognosis | Kidney - pathology | Humans | Lupus Nephritis - physiopathology | Mortality | Lupus Nephritis - therapy | Lupus Nephritis - immunology | Kidney - physiopathology | Lupus Nephritis - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
by Bertsias, George K and Tektonidou, Maria and Amoura, Zahir and Aringer, Martin and Bajema, Ingeborg and Berden, Jo H M and Boletis, John and Cervera, Ricard and Dörner, Thomas and Doria, Andrea and Ferrario, Franco and Floege, Jürgen and Houssiau, Frederic A and Ioannidis, John P A and Isenberg, David A and Kallenberg, Cees G M and Lightstone, Liz and Marks, Stephen D and Martini, Alberto and Moroni, Gabriela and Neumann, Irmgard and Praga, Manuel and Schneider, Matthias and Starra, Argyre and Tesar, Vladimir and Vasconcelos, Carlos and van Vollenhoven, Ronald F and Zakharova, Helena and Haubitz, Marion and Gordon, Caroline and Jayne, David and Boumpas, Dimitrios T and European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2012, Volume 71, Issue 11, pp. 1771 - 1782
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN). Methods The available evidence was systematically... 
LONG-TERM | CONTROLLED-TRIAL | IMMUNOSUPPRESSIVE THERAPY | ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY | RISK-FACTORS | ERYTHEMATOSUS PATIENTS | COATED MYCOPHENOLATE SODIUM | TERM-FOLLOW-UP | RHEUMATOLOGY | DOSE PULSE METHYLPREDNISOLONE | DISEASE-ACTIVITY | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Kidney - drug effects | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Lupus Nephritis - drug therapy | Male | Evidence-Based Medicine | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Pregnancy | Mycophenolic Acid - therapeutic use | Biopsy | Lupus Nephritis - urine | Adult | Female | Disease Management | Drug Substitution | Drug Therapy, Combination | Child | Lupus Nephritis - diagnosis | Usage | Nephritis | Care and treatment | Hydroxychloroquine | Medical case management | Immunotherapy | Dosage and administration | Diagnosis | Drug therapy | Methods | Lupus | Anticoagulants | Rodents | Medical prognosis | Preeclampsia | Adults | Blood pressure | Kidney diseases | Drug dosages | Index Medicus | Recommendations | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights